EyeRising and Sky-n1201 reached ANSI group 1 limits within exposure times of 2.8 and 1.4 seconds for a 7-mm pupil.

“How do you operationalize what is a coffee flavor versus mocha Frappuccino flavor?” he said. HealthDay News — The Food and Drug Administration (FDA) may allow some flavored e-cigarettes back on the ...

On March 3, the CDC issued a Level 2 travel notice, advising travelers to take extra precautions. The agency says poliovirus is circulating in countries across Africa, the Middle East and Europe.

Increase from 0.16 to 0.44 new monthly dispensations per 1,000 people reported between January 2016 and June 2024 ...

From 2023, there was a decrease in use of metabolic and bariatric surgery, with stronger decline for sleeve gastrectomy.

New data show bimekizumab is the first approved biologic to achieve superior outcomes in psoriatic arthritis vs an IL-23 inhibitor.

HealthDay News — For patients with systemic lupus erythematosus (SLE), obinutuzumab, a glycoengineered type II anti-CD20 monoclonal antibody, is superior to placebo, according to a study published ...

The approval was based on data from the POETYK PsA-1 and POETYK PsA-2 trials, which evaluated the efficacy and safety of ...

Povetacicept significantly reduced proteinuria in patients with IgA nephropathy in the RAINIER trial, supporting an upcoming FDA submission.

Prasad's stint included several controversial vaccine decisions; the FDA is now searching for a new head for its vaccine division.

Findings seen in pilot study of older adults with mild cognitive impairment, but other coprimary outcomes did not meet significance thresholds.

Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.